Hydrochloric Acid → HCID 67373322、化合物

HRID 1972003ノート

反応式

HRID 1972003 の反応式
[ClH:1].Cl.[CH2:3]([C:7]1[N:8]=[N:9][C:10]([O:30][CH:31]2[CH2:36][CH2:35][N:34]([CH3:37])[CH2:33][CH2:32]2)=[CH:11][C:12]=1[C:13]1[CH:14]=[CH:15][C:16]([O:23][CH:24]2[CH2:29][CH2:28][CH2:27][CH2:26][CH2:25]2)=[C:17]([NH:19][C:20](=[O:22])[CH3:21])[CH:18]=1)[CH2:4][CH2:5][CH3:6].[CH:38](=O)[CH:39]([CH3:41])[CH3:40].C(O[BH-](OC(=O)C)OC(=O)C)(=O)C.[Na+].C([Cl:60])(=O)C.CCN(C(C)C)C(C)C.Cl>C(Cl)Cl.C(O)(=O)C.O.CCOC(C)=O.CN(C1C=CN=CC=1)C.CCOCC>[ClH:60].[ClH:1].[CH2:3]([C:7]1[N:8]=[N:9][C:10]([O:30][CH:31]2[CH2:36][CH2:35][N:34]([CH3:37])[CH2:33][CH2:32]2)=[CH:11][C:12]=1[C:13]1[CH:14]=[CH:15][C:16]([O:23][CH:24]2[CH2:29][CH2:28][CH2:27][CH2:26][CH2:25]2)=[C:17]([N:19]([CH2:38][CH:39]([CH3:41])[CH3:40])[C:20](=[O:22])[CH3:21])[CH:18]=1)[CH2:4][CH2:5][CH3:6]

参加物

12

反応物 6

HCID 313Hydrochloric AcidHCID 6367Acetyl chlorideHCID 6561IsobutyraldehydeHCID 81531DiisopropylethylamineHCID 5049666Sodium triacetoxyborohydrideHCID 67373992HCID 67373992、化合物

生成物 1

HCID 67373322HCID 67373322、化合物収率 33.6%

試薬・触媒・溶媒 5

HCID 176Acetic Acid触媒HCID 142844-(Dimethylamino)pyridine触媒HCID 3283Diethyl Ether溶媒HCID 6344Dichloromethane溶媒2 回HCID 22728543Water ethylacetate溶媒

実験手順

To a solution of 5-[3-butyl-6-(1-methyl-piperidin-4-yloxy)-pyridazin-4-yl]-2-cyclohexyloxy-phenylamine (Example 62, 0.2 mmol, 88 mg) in DCM (2.0 mL) was added isobutyraldehyde (0.3 mmol, 28 μL), and 1 drop of acetic acid. Then sodium triacetoxyborohydride (0.6 mmol, 127 mg) was added. The mixture was stirred at room temperature for 1 hour then condensed. The mixture was then diluted with water/EtOAc. The solvent was removed in vacuo and the residue was again dissolved in DCM (2.0 mL) at 0° C., added acetyl chloride (0.4 mmol, 29 μL), DIEA (0.6 mmol, 105 μL) and DMAP (5 mg). And the mixture was stirred at room temperature for 1 hour. It was then condensed in vacuo and the residue was purified by silica gel chromatography (DCM to DCM+10% 2N NH3 in MeOH) to give a colorless sticky solid, which was dissolved in DCM (1.0 mL), 2N HCl in ether (1.0 mL) was added, kept at room temperature for 10 min, condensed, triturated with hexanes to provide the title compound (41 mg). LCMS: m/z 537 [M+1]. 1H NMR (400 MHz, CD3OD): δ 7.40-7.43 (1H, m), 7.28-7.35 (2H, m), 7.07 (1H, s), 5.52 (1H, bs), 4.53-4.59 (1H, m), 3.65-3.71 (1H, m), 3.29-3.47 (7H, m), 2.92-2.97 (2H, m), 2.89 (3H, s), 2.18-2.37 (4H, m), 1.99-2.07 (2H, m), 1.84 (3H, s), 1.25-1.83 (9H, m), 1.18-1.26 (2H, m), 0.91-0.95 (6H, m), 0.80 (3H, t).

後処理

  1. customcondensed
  2. customThe solvent was removed in vacuo
  3. dissolutionthe residue was again dissolved in DCM (2.0 mL) at 0° C.
  4. stirringAnd the mixture was stirred at room temperature for 1 hour
  5. customcondensed in vacuo
  6. customthe residue was purified by silica gel chromatography (DCM to DCM+10% 2N NH3 in MeOH)
  7. customto give a colorless sticky solid, which
  8. waitkept at room temperature for 10 min
  9. customcondensed
  10. customtriturated with hexanes

出典と根拠

ORDレコード
ord-86191449f9a343da8bd35c6830a87b72
出典データセット
uspto-grants-2013_04
特許番号
US08431575B2

反応ノート

読み込み中…